Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-0054 for Stem Cell Mobilization in Multiple Myeloma and Lymphoma
NCT01018979Phase 2Completed
- Sponsor
- GPCR Therapeutics
- Start
- Feb 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of burixafor in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by GPCR Therapeutics. Started Feb 2010; status: completed.
02
Drugs
burixafor
03
Conditions
multiple myeloma (MM)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01018979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018979.